5 Undervalued Blue Chip Stocks To Buy According to Wall Street Analysts

4. Merck & Co., Inc. (NYSE:MRK)

Share Price Upside: 18%

Merck & Co., Inc. (NYSE:MRK) is a global pharmaceutical giant with tens of thousands of employees worldwide. The firm has beaten analyst EPS estimates in all four of its latest quarters. Its average share price target is $124.32 and the stock is rated Buy on average.

After scouring through 943 hedge funds for their March quarter of 2023 investments, Insider Monkey discovered that 75 had bought the firm’s shares. Merck & Co., Inc. (NYSE:MRK)’s biggest investor in our database is Ken Fisher’s Fisher Asset Management since it owns 12.3 million shares that are worth $1.3 billion.

Follow Merck & Co. Inc. (NYSE:MRK)